NCT03254420View on ClinicalTrials.gov

Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.

NAActive, not recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

September 15, 2022

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
DEVICE

Calypso beacon implant

Calypso beacon implant before radiotherapy

RADIATION

moderate hypofractionation Radiotherapy

moderate hypofractionation Radiotherapy

Trial Locations (1)

34298

Institut regional du Cancer - Val d Aurelle, Montpellier

All Listed Sponsors
lead

Institut du Cancer de Montpellier - Val d'Aurelle

OTHER

NCT03254420 - Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. | Biotech Hunter | Biotech Hunter